| Product Type | Impurity Standards |
| CAT. No. | MRL-A116009 |
| CAS. No. | NA |
| Mol. Formula | C11H11Cl2N3O5 |
| Mol. Weight | 336.13 |
| Synonyms | NA |
| Chemical Name | Ethyl N-(2,3-dichloro-6-nitrobenzyl)-N-nitrosoglycinate |
| HSN Code | 38229010 |
| Country of Origin | India |
| Stock Status | Custom Synthesis |
Nitrosamines can be formed through various chemical processes, including the reaction between nitrites and secondary amines in certain conditions. It is a N-Nitroso of secondary amine present in Anagrelide. Nitrosamines are part of a broader class of compounds known as N-nitroso compounds. Anagrelide, a quinazolinone derivative, inhibits phosphodiesterase activity, particularly phosphodiesterase-III, leading to decreased platelet production in the bone marrow. Its chemical structure, with a quinazolinone core and chlorine substitutions, is crucial for its pharmacological activity. Anagrelide is employed in the treatment of essential thrombocythemia, a condition characterized by elevated platelet levels, by selectively reducing platelet production. Administered orally, it is often considered when other treatments are not well-tolerated, providing a targeted approach to managing platelet counts and mitigating the risk of thrombotic events in affected individuals. Buy high quality N-Nitroso Anagrelide from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of N-Nitroso Anagrelide